The SARS-CoV-2 Spike variant D614G favors an open conformational state

Sci Adv. 2021 Apr 16;7(16):eabf3671. doi: 10.1126/sciadv.abf3671. Print 2021 Apr.

Abstract

The COVID-19 (coronavirus disease 2019) pandemic underwent a rapid transition with the emergence of a dominant viral variant (from the "D-form" to the "G-form") that carried an amino acid substitution D614G in its "Spike" protein. The G-form is more infectious in vitro and is associated with increased viral loads in the upper airways. To gain insight into the molecular-level underpinnings of these characteristics, we used microsecond all-atom simulations. We show that changes in the protein energetics favor a higher population of infection-capable states in the G-form through release of asymmetry present in the D-form inter-protomer interactions. Thus, the increased infectivity of the G-form is likely due to a higher rate of profitable binding encounters with the host receptor. It is also predicted to be more neutralization sensitive owing to enhanced exposure of the receptor binding domain, a key target region for neutralizing antibodies. These results are critical for vaccine design.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Angiotensin-Converting Enzyme 2 / chemistry
  • Angiotensin-Converting Enzyme 2 / metabolism
  • Antibodies, Neutralizing / immunology
  • COVID-19 / pathology
  • COVID-19 / virology
  • Glycosylation
  • Humans
  • Hydrogen Bonding
  • Molecular Dynamics Simulation
  • Mutation
  • Protein Binding
  • Protein Structure, Quaternary
  • Protein Subunits / chemistry
  • Protein Subunits / immunology
  • SARS-CoV-2 / genetics*
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / isolation & purification
  • Spike Glycoprotein, Coronavirus / chemistry*
  • Spike Glycoprotein, Coronavirus / metabolism
  • Virus Internalization

Substances

  • Antibodies, Neutralizing
  • Protein Subunits
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2